🚀 VC round data is live in beta, check it out!
Relief Therapeutics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Relief Therapeutics and similar public comparables like Eli Lilly, Johnson & Johnson, AbbVie, Roche and more.
Relief Therapeutics Overview
About Relief Therapeutics
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products, and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development, such as RLF-TD011 and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast, among others. Geographically, the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
Founded
2013
HQ
Employees
31
Website
Sectors
Financials (FY)
Market Cap
—
Relief Therapeutics Stock Performance
Relief Therapeutics has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRelief Therapeutics Valuation Multiples
Relief Therapeutics Financial Valuation Multiples
As of March 11, 2026, Relief Therapeutics has market cap of —.
Equity research analysts estimate Relief Therapeutics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Relief Therapeutics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Relief Therapeutics Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eli Lilly | XXX | XXX | XXX | XXX | XXX | XXX |
| Johnson & Johnson | XXX | XXX | XXX | XXX | XXX | XXX |
| AbbVie | XXX | XXX | XXX | XXX | XXX | XXX |
| Roche | XXX | XXX | XXX | XXX | XXX | XXX |
| Novartis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Relief Therapeutics M&A Activity
Relief Therapeutics acquired XXX companies to date.
Last acquisition by Relief Therapeutics was on XXXXXXXX, XXXXX. Relief Therapeutics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Relief Therapeutics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRelief Therapeutics Investment Activity
Relief Therapeutics invested in XXX companies to date.
Relief Therapeutics made its latest investment on XXXXXXXX, XXXXX. Relief Therapeutics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Relief Therapeutics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Relief Therapeutics
| When was Relief Therapeutics founded? | Relief Therapeutics was founded in 2013. |
| Where is Relief Therapeutics headquartered? | Relief Therapeutics is headquartered in Switzerland. |
| How many employees does Relief Therapeutics have? | As of today, Relief Therapeutics has over 31 employees. |
| Is Relief Therapeutics publicly listed? | Yes, Relief Therapeutics is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of Relief Therapeutics? | Relief Therapeutics trades under RLF ticker. |
| When did Relief Therapeutics go public? | Relief Therapeutics went public in 2013. |
| Who are competitors of Relief Therapeutics? | Relief Therapeutics main competitors are Eli Lilly, Johnson & Johnson, AbbVie, Roche. |
| Is Relief Therapeutics profitable? | No, Relief Therapeutics is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.